Postural Orthostatic Tachycardia Syndrome as a Manifestation of Post-COVID-19 Syndrome
The pandemic of coronavirus infection, the complex and insufficiently studied mechanisms of which cause disorders in the functions of many organs and systems of the body, has led to the emergence of new problems that are far from being resolved. Researchers note the difficulty in predicting the cour...
Saved in:
Main Author: | E. L. Trisvetova |
---|---|
Format: | Article |
Language: | English |
Published: |
Столичная издательская компания
2022-05-01
|
Series: | Рациональная фармакотерапия в кардиологии |
Subjects: | |
Online Access: | https://www.rpcardio.online/jour/article/view/2716 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Post-COVID Syndrome and Tachycardia: Theoretical Base and Treatment Experience
by: V. I. Podzolkov, et al.
Published: (2021-05-01) -
Comparative cohort study of post-acute COVID-19 infection with a nested, randomized controlled trial of ivabradine for those with postural orthostatic tachycardia syndrome (the COVIVA study)
by: David Saunders, et al.
Published: (2025-07-01) -
ORTHOSTATIC TACHYCARDIA: DIAGNOSTIC AND PROGNOSTIC VALUE OF VERY LOW FREQUENCY OF HEART RATE VARIABILITY
by: A. N. Fleishman, et al.
Published: (2014-08-01) -
Changes in NT-proBNP levels in patients with sinus tachycardia after COVID-19
by: V. I. Podzolkov, et al.
Published: (2023-01-01) -
Comparative efficacy of ivabradine and beta-blockers in the treatment of tachycardia in patients after COVID-19
by: V. I. Podzolkov, et al.
Published: (2022-08-01)